1. Clinical characteristics of psoriasis in inflammatory bowel disease patients. (10th April 2017) Authors: Pescitelli, L.; Gianotta, M.; Ricceri, F.; Lazzeri, L.; Milla, M.; Prignano, F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 9(2017) Page Start: e414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical experience with infliximab biosimilar in psoriasis. (15th November 2017) Authors: Ricceri, F.; Pescitelli, L.; Lazzeri, L.; Prignano, F. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical experience with infliximab biosimilar in psoriasis. (1st December 2017) Authors: Ricceri, F.; Pescitelli, L.; Lazzeri, L.; Prignano, F. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First case of secukinumab successful therapy in a very elderly psoriatic patient. Issue 5 (13th September 2018) Authors: Ricceri, F.; Pescitelli, L.; Lazzeri, L.; Di Cesare, A.; Prignano, F. Journal: Dermatologic therapy Issue: Volume 31:Issue 5(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lichen planus triggered by CT‐P13 and recurrence during secukinumab treatment. (1st January 2018) Authors: Maglie, R.; Di Cesare, A.; Lazzeri, L.; Pescitelli, L.; Ricceri, F.; Vannucchi, M.; Massi, D.; Prignano, F. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lichen planus triggered by CT‐P13 and recurrence during secukinumab treatment. (29th December 2017) Authors: Maglie, R.; Di Cesare, A.; Lazzeri, L.; Pescitelli, L.; Ricceri, F.; Vannucchi, M.; Massi, D.; Prignano, F. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reduction in psoriasis related pruritus during biologic therapy*. Issue 3 (27th November 2016) Authors: Lazzeri, L.; Pescitelli, L.; Tripo, L.; Ricceri, F.; Prignano, F. Journal: Dermatologic therapy Issue: Volume 30:Issue 3(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. (15th May 2017) Authors: Ricceri, F.; Pescitelli, L.; Lazzeri, L.; Di Cesare, A.; Prignano, F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 11(2017) Page Start: e486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Risk of acute infections in psoriatic patients during biologic therapies is linked to gender. (20th May 2019) Authors: Di Cesare, A.; Bianchi, C.; Pescitelli, L.; Ricceri, F.; Rosi, E.; Pimpinelli, N.; Prignano, F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 10(2019) Page Start: e362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result. Issue 1 (5th February 2013) Authors: Ricceri, F.; Pescitelli, L.; Tripo, L.; Bassi, A.; Prignano, F. Journal: Dermatologic therapy Issue: Volume 26:Issue 1(2013) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗